WO2010038239A3 - Pharmaceutical composition comprising coenzyme q10 - Google Patents

Pharmaceutical composition comprising coenzyme q10 Download PDF

Info

Publication number
WO2010038239A3
WO2010038239A3 PCT/IN2009/000525 IN2009000525W WO2010038239A3 WO 2010038239 A3 WO2010038239 A3 WO 2010038239A3 IN 2009000525 W IN2009000525 W IN 2009000525W WO 2010038239 A3 WO2010038239 A3 WO 2010038239A3
Authority
WO
WIPO (PCT)
Prior art keywords
coenzyme
pharmaceutical composition
solution
solubilizer
administration
Prior art date
Application number
PCT/IN2009/000525
Other languages
French (fr)
Other versions
WO2010038239A2 (en
Inventor
Saumya Sharma
Srinath Thakur
Swati Setty
Rajesh Kulkarni
Shirishkumar Kulkarni
Original Assignee
Saumya Sharma
Srinath Thakur
Swati Setty
Rajesh Kulkarni
Shirishkumar Kulkarni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saumya Sharma, Srinath Thakur, Swati Setty, Rajesh Kulkarni, Shirishkumar Kulkarni filed Critical Saumya Sharma
Priority to EP09817367A priority Critical patent/EP2341923A2/en
Publication of WO2010038239A2 publication Critical patent/WO2010038239A2/en
Publication of WO2010038239A3 publication Critical patent/WO2010038239A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Abstract

A pharmaceutical composition for administration in gum pockets caused by periodontal disease, consisting: coenzyme Q10 and pharmaceutically acceptable excipients selected from the group comprising solubilizer; biodegradable polymer; solvent, and/or combinations thereof. A process for making a pharmaceutical composition for administration in pockets in gums caused by periodontal disease, consisting: coenzyme Q10 and pharmaceutically acceptable excipients wherein the solubilizer was dissolved in the solvent with stirring to obtain a clear solution followed by addition of the biodegradable polymer to this solution with stirring to obtain a clear solution; to this solution CoQ10 was added with vortexing to form a uniform suspension.
PCT/IN2009/000525 2008-09-26 2009-09-25 Pharmaceutical composition comprising coenzyme q10 WO2010038239A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09817367A EP2341923A2 (en) 2008-09-26 2009-09-25 Pharmaceutical composition comprising coenzyme q10

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2073/MUM/2008 2008-09-26
IN2073MU2008 2008-09-26

Publications (2)

Publication Number Publication Date
WO2010038239A2 WO2010038239A2 (en) 2010-04-08
WO2010038239A3 true WO2010038239A3 (en) 2010-06-24

Family

ID=42073973

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000525 WO2010038239A2 (en) 2008-09-26 2009-09-25 Pharmaceutical composition comprising coenzyme q10

Country Status (2)

Country Link
EP (1) EP2341923A2 (en)
WO (1) WO2010038239A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117582422A (en) * 2023-10-31 2024-02-23 广东润和生物科技有限公司 Coenzyme Q10 composition containing sunflower seed oil and preparation process thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278201A (en) * 1988-10-03 1994-01-11 Atrix Laboratories, Inc. Biodegradable in-situ forming implants and methods of producing the same
US6200550B1 (en) * 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278201A (en) * 1988-10-03 1994-01-11 Atrix Laboratories, Inc. Biodegradable in-situ forming implants and methods of producing the same
US6200550B1 (en) * 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10

Also Published As

Publication number Publication date
WO2010038239A2 (en) 2010-04-08
EP2341923A2 (en) 2011-07-13

Similar Documents

Publication Publication Date Title
MY149627A (en) Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
MX2011011374A (en) Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof.
WO2008122965A3 (en) Pharmaceutical cyclosporin compositions
MX2011012122A (en) Thiophene derivatives.
EP3895699A3 (en) Pharmaceutical compositions comprising iron oxy-hydroxide
TW200640503A (en) Drug formulations having improved pharmacokinetic properties
BR112012003283A8 (en) pharmaceutically acceptable salt of an amphiphilic photosensitizing agent, pharmaceutical composition, product, kit, use of a pharmaceutically acceptable salt of an amphiphilic photosensitizing agent, and method of introducing a drug molecule into the cytosol of a cell in a patient.
WO2006125620A3 (en) Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
WO2010039762A3 (en) Pharmaceutical compositions comprising boronic acid compounds
WO2011015634A3 (en) Controlled release formulations of lipocalin muteins
WO2009041666A1 (en) Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
ATE460401T1 (en) 1,2,4,5-TETRAHYDRO-3H-BENZAZEPINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
WO2010151644A3 (en) Antineoplastic hydrogels, and enzyme-instructed preparations thereof
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
WO2007144169A3 (en) Entacapone-derivatives
WO2008022345A3 (en) Compositions and methods for inhibiting cytochrome p450
WO2010045281A3 (en) Stable aqueous formulations of water insoluble or poorly soluble drugs
MX2010005198A (en) Pharmaceutical compositions.
GEP20115186B (en) Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same
WO2009066956A3 (en) Lyophilized pharmaceutical composition with improved reconstitution time containing taxane derivatives and method of manufacturing the same
WO2011064558A3 (en) Pharmaceutical composition
EP2491951A4 (en) Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient
WO2010038239A3 (en) Pharmaceutical composition comprising coenzyme q10
WO2008122994A3 (en) Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
UA87152C2 (en) Solid pharmaceutical composition containing mirtazapine and method for preparation thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09817367

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009817367

Country of ref document: EP